Home > News > ACLARA Receives 4 U.S. Patents
April 5th, 2004
ACLARA Receives 4 U.S. Patents
ACLARA BioSciences announced the issuance of four U.S. patents that strengthen the intellectual property around its eTag technology: Nos. 6,682,887 and No. 6,686,152 with claims related to certain eTag applications; No. 6,673,550 with broad claims related to certain specific eTag reporter molecules including assays related to protein and protein complex expression; and No. 6,685,813 with claims related to eTag sample handling in a nanofluidic setting.
Silicon Valley-Based Foresight Valuation Launches STR-IP™, a New Initiative for Startups to Discover the Value of Their Intellectual Property December 18th, 2014
Chemists Fabricate Novel Rewritable Paper: An attractive alternate to regular paper, UC Riverside-developed technology helps address increasing problems in environment and resource sustainability December 2nd, 2014
Dicerna Announces License Agreement with Tekmira to Advance Dicerna’s PH1 Development Program November 17th, 2014
First genetic-based tool to detect circulating cancer cells in blood: NanoFlares light up individual cells if breast cancer biomarker is present November 17th, 2014